Effects of RAS on the genesis of embryonal rhabdomyosarcoma
- David M. Langenau1,
- Matthew D. Keefe1,
- Narie Y. Storer1,
- Jeffrey R. Guyon2,
- Jeffery L. Kutok3,
- Xiuning Le1,
- Wolfram Goessling1,
- Donna S. Neuberg4,
- Louis M. Kunkel2, and
- Leonard I. Zon1,5
- 1 Stem Cell Program and Division of Hematology/Oncology, Children’s Hospital Boston and Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA;
- 2 Program in Genomics and Howard Hughes Medical Institute at Children’s Hospital Boston, Boston, Massachusetts 02115, USA;
- 3 Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts 02115, USA;
- 4 Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA
Abstract
Embryonal rhabdomyosarcoma (ERMS) is a devastating cancer with specific features of muscle differentiation that can result from mutational activation of RAS family members. However, to date, RAS pathway activation has not been reported in a majority of ERMS patients. Here, we have created a zebrafish model of RAS-induced ERMS, in which animals develop externally visible tumors by 10 d of life. Microarray analysis and cross-species comparisons identified two conserved gene signatures found in both zebrafish and human ERMS, one associated with tumor-specific and tissue-restricted gene expression in rhabdomyosarcoma and a second comprising a novel RAS-induced gene signature. Remarkably, our analysis uncovered that RAS pathway activation is exceedingly common in human RMS. We also created a new transgenic coinjection methodology to fluorescently label distinct subpopulations of tumor cells based on muscle differentiation status. In conjunction with fluorescent activated cell sorting, cell transplantation, and limiting dilution analysis, we were able to identify the cancer stem cell in zebrafish ERMS. When coupled with gene expression studies of this cell population, we propose that the zebrafish RMS cancer stem cell shares similar self-renewal programs as those found in activated satellite cells.
Keywords
Footnotes
-
↵5 Corresponding author.
↵5 E-MAIL zon{at}enders.tch.harvard.edu; FAX (617) 730-0222.
-
Supplemental material is available at http://www.genesdev.org.
-
Article published online ahead of print. Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.1545007
-
- Received February 23, 2007.
- Accepted April 3, 2007.
- Copyright © 2007, Cold Spring Harbor Laboratory Press